SCHEMBL14485035

SCHEMBL14485035

CCC(Br)(Br)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL347172 0.76
SCHEMBL11098098 0.72
SCHEMBL10834772 0.71
SCHEMBL10020718 0.69
SCHEMBL19287773 0.67
SCHEMBL12588448 0.67
SCHEMBL21932503 0.67
SCHEMBL7170924 0.67 TSHR (0.31)
SCHEMBL9787340 0.64
SCHEMBL1627122 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108101739-B Method for continuously preparing 3,3, 3-trifluoro-1, 2-propanediol 西安近代化学研究所 2021-04-13 CN disclosed
EP-2729448-A1 COMPOUNDS FOR THE TREATMENT OF HIV Gilead Sciences, Inc. (US) 2014-05-14 EP disclosed
WO-2013006738-A1 COMPOUNDS FOR THE TREATMENT OF HIV GILEAD SCIENCES, INC. (US) 2013-01-10 WO disclosed